Barry Lifson, MD
Urology · Charleston, SCNPI 1659319200
Payments from drug & device makers
Across 66 payments — averaging $66.99 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Procept Biorobotics Corporation$2K
- Boston Scientific$1K
- Dendreon Pharmaceuticals LLC$394
- Calyxo, Inc.$163
- Astellas Pharma US Inc$139
- Urovant Sciences Inc$106
- plus $769 from 14 others
What the payments were for
- Travel & lodging$50511%
- Food & beverage$3,91789%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Procept Biorobotics Corporation | 12 | $1,509 |
| Boston Scientific | 20 | $1,342 |
| Dendreon Pharmaceuticals LLC | 4 | $394 |
| Calyxo, Inc. | 2 | $163 |
| Astellas Pharma US Inc | 7 | $139 |
| Urovant Sciences Inc | 1 | $106 |
| Sanofi | 1 | $105 |
| Agiliti Surgical, Inc. | 1 | $101 |
| Ambu Inc. | 1 | $94 |
| Cycle Pharmaceuticals Inc | 1 | $94 |
| Olympus America Inc. | 2 | $90 |
| Tolmar Pharmaceuticals, Inc. | 4 | $88 |
| Pfizer | 3 | $51 |
| Teleflex LLC | 1 | $43 |
| AbbVie | 1 | $20 |
| 180 Medical, Inc. | 1 | $19 |
| Endo Pharmaceuticals Inc. | 1 | $18 |
| ABC Home Medical Supply, Inc. | 1 | $16 |
| Coloplast | 1 | $14 |
| C. R. Bard, Inc. & Subsidiaries | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- AquaBeam Robotic System$875
- AQUABEAM SYSTEM$490
- rezum Generator$275
- PROVENGE$256
- CVAC Aspiration System$144
- Moses$144
- GreenLight XPS$111
- GENERAL - THERAPIES$108
- GEMTESA$106
- JEVTANA$105
- Moses 550 D\F\L$101
- Sonablate HIFU$101
- Siemens Healthineers Varian CryoCare$101
- Boston Scientific Lumenis Pulse 120H Holmium Laser w/ MOSES Technology$101
- Olympus SOLTIVE TFL Laser$101
- Quanta System Fiber Dust TFL Laser$101
How this compares
$4,421 in reported general payments places this provider in the 55th percentile of 196 urology providers in South Carolina.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| MyrbetriqMirabegron | 106 | $59,417 |
| GemtesaVibegron | 42 | $30,476 |
| Mirabegron ErMirabegron | 18 | $7,962 |
| Tamsulosin Hcl | 259 | $3,889 |
| Solifenacin Succinate | 126 | $3,124 |
| Methenamine Hippurate | 36 | $2,853 |
| Finasteride | 90 | $1,530 |
| Testosterone Cypionate | 27 | $1,419 |
| Testosterone | 25 | $1,027 |
| Potassium Citrate ErPotassium Citrate | 16 | $526 |
| Oxybutynin Chloride ErOxybutynin Chloride | 25 | $424 |
| NitrofurantoinNitrofurantoin Macrocrystal | 12 | $338 |
| Cephalexin | 32 | $218 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 25 | $165 |
| Ciprofloxacin Hcl | 37 | $162 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Astellas Pharma US IncMyrbetriq | $139 | $59,417106 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 55th percentile of 196 urology providers in South Carolina.
Other urology in Charleston
- Sandip PrasadCharleston$2.4M
- Stephen SavageCharleston$2.1M
- Thomas KeaneCharleston$281K
- Matvey TsivianCharleston$101K
- Robert GrubbCharleston$90K
- Paul WombleCharleston$88K
- Ian MarshallCharleston$60K
- John BrittonCharleston$15K
- John AdamsCharleston$15K
- Bradley SteeleCharleston$12K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.